30-Jul-2026
TipRanks (Thu, 30-Jul 9:40 AM ET)
Truist Financial Reaffirms Their Buy Rating on Option Care Health (OPCH)
TipRanks (Thu, 30-Jul 7:58 AM ET)
Bank of America Securities Keeps Their Hold Rating on Option Care Health (OPCH)
TipRanks (Thu, 30-Jul 6:57 AM ET)
Option Care Health Inc Earnings Call Shows Cautious Momentum
TipRanks (Wed, 29-Jul 8:28 PM ET)
TipRanks (Wed, 29-Jul 11:40 AM ET)
Option Care Health beats top-line and bottom-line estimates; updates FY26 outlook
Seeking Alpha News (Wed, 29-Jul 7:36 AM ET)
Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
Globe Newswire (Wed, 29-Jul 7:00 AM ET)
Here are the major earnings before the open Wednesday
Seeking Alpha News (Tue, 28-Jul 6:00 PM ET)
Option Care Health Q2 2026 Earnings Preview
Seeking Alpha News (Tue, 28-Jul 10:18 AM ET)
Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
Globe Newswire (Thu, 9-Jul 4:05 PM ET)
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.
Option Care Health trades on the NASDAQ stock market under the symbol OPCH.
As of July 30, 2026, OPCH stock price declined to $22.46 with 4,704,116 million shares trading.
OPCH has a beta of 0.39, meaning it tends to be less sensitive to market movements. OPCH has a correlation of 0.01 to the broad based SPY ETF.
OPCH has a market cap of $3.36 billion. This is considered a Mid Cap stock.
Last quarter Option Care Health reported $1 billion in Revenue and $.45 earnings per share. This beat revenue expectation by $23 million and exceeded earnings estimates by $.03.
In the last 3 years, OPCH traded as high as $36.80 and as low as $18.01.
The top ETF exchange traded funds that OPCH belongs to (by Net Assets): IJH, VTI, IWM, VB, VBK.
OPCH has underperformed the market in the last year with a return of -25.5%, while the SPY ETF gained +17.9%. In the last 3 month period, OPCH fell short of the market, returning -16.4%, while SPY returned +4.5%. However, in the most recent 2 weeks OPCH has outperformed the stock market by returning +1.7%, while SPY returned -1.7%.
OPCH support price is $23.39 and resistance is $24.47 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPCH shares will trade within this expected range on the day.